Literature DB >> 18489843

Treating high-density lipoprotein cholesterol: a return to inhibition of cholesteryl ester transfer protein?

Patrick Duriez1.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18489843     DOI： 10.1007/s11883-008-0027-x

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  24 in total

1.  The CETP TaqIB polymorphism is associated with the risk of sudden death in type 2 diabetic patients.

Authors:  Isabelle Porchay-Baldérelli; Franck Péan; Naïma Bellili; Riphed Jaziri; Michel Marre; Frédéric Fumeron
Journal:  Diabetes Care       Date:  2007-07-31       Impact factor: 19.112

Review 2.  High-density lipoprotein as a therapeutic target: a systematic review.

Authors:  Inder M Singh; Mehdi H Shishehbor; Benjamin J Ansell
Journal:  JAMA       Date:  2007-08-15       Impact factor: 56.272

3.  Oxidized high-density lipoproteins modulate endothelin secretion by adult bovine aortic endothelial cells.

Authors:  F Martin-Nizard; H Sqalli-Houssaini; E Walters-Laporte; A Boullier; J C Fruchart; P Duriez
Journal:  J Cardiovasc Risk       Date:  1995-06

4.  Effect of torcetrapib on the progression of coronary atherosclerosis.

Authors:  Steven E Nissen; Jean-Claude Tardif; Stephen J Nicholls; James H Revkin; Charles L Shear; William T Duggan; Witold Ruzyllo; William B Bachinsky; Gabriel P Lasala; Gregory P Lasala; E Murat Tuzcu
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

5.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

Review 6.  High-density lipoprotein cholesterol and residual cardiometabolic risk in metabolic syndrome.

Authors:  Christopher P Cannon
Journal:  Clin Cornerstone       Date:  2007

7.  Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.

Authors:  Michiel L Bots; Frank L Visseren; Gregory W Evans; Ward A Riley; James H Revkin; Charles H Tegeler; Charles L Shear; William T Duggan; Ralph M Vicari; Diederick E Grobbee; John J Kastelein
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321

8.  High density lipoproteins stimulate the production and secretion of endothelin-1 from cultured bovine aortic endothelial cells.

Authors:  R M Hu; M Y Chuang; B Prins; M L Kashyap; H J Frank; A Pedram; E R Levin
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  Lifetime risk for developing dyslipidemia: the Framingham Offspring Study.

Authors:  Mark R Cobain; Michael J Pencina; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Am J Med       Date:  2007-05-11       Impact factor: 4.965

10.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Authors:  Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.